161. Why sharing patents for COVID-19 medicines is not enough Trade Talks

    • Business

Despite the Medicines Patent Pool, COVID-19 treatments remain scarce globally. Prashant Yadav explains what more is needed.

Despite the Medicines Patent Pool, COVID-19 treatments remain scarce globally. Prashant Yadav explains what more is needed.